The Failing Heart and EC-coupling Flashcards

1
Q

What is excitation-contraction coupling?

A

The process whereby action potential triggers myocyte to contract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the B-adrenergic receptor signalling pathway

A
Noradrenaline/ adrenaline
B1-adrenergic receptor
Activates GTP-binding protein (Gs)
Stimulates adenylyl cyclase (AC)
cAMP
PKA
Phosphorylates several proteins related to EC-coupling (e.g. PLV, L-type Ca2+ channels, RyRs, Tropinin I and myosin binding protein C)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is heart failure

A

Inability of the heart to supple adequate blood flow (and oxygen deliver) to tissues and organs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Decreased perfusion of organs leads to

A

Reduced exercise capacity
Shortness of breath
Fatigue
Organ dysfunction (e.g. renal failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Symptoms of heart failure

A
Enlarges heart
Weakened heart muscle
Blood is pumped at reduced volume
Less blood fills the chambers
Weakness and fatigue
Shortness of breath
Swollen feet, ankles, abdomen, or veins in the neck.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is myocardial infarction?

A

Heart attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Progression to Heart failure begins with stage A causing diastolic dysfunction. What can cause this?

A

Hypertension, coronary artery disease, valvular disease, obesity, diabetes and kidney disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What stages occur after stage A of heart dysfunction?

A

Diastolic dysfunction, Increase in atheroscelerosis, Cardiac ischemia, arrhythmias and ventricular dysfunction, ventricular enlargement, heart failure, pump failure, death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathophysiology of cardiac heart failure

A

Decreased SV and CO
Increased ED pressure
Ventricular dilation or hypertrophy
Impaired filling (diastolic dysfunction)
Reduced ejection fraction (systolic dysfunction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathophysiology of vascular heart failure

A
Increased systemic vascular resistance
Decreased arterial pressure
Impaired arterial pressure
Impaired organ dysfunction
Decreased venous compliance
Increased venous pressure
Increased blood volume
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What compensatory mechanisms of heart failure (Cardiac)

A

Cardiac:
Frank-starling mechanisms- reduce output. Cardiac force therefore increase due to starling law; but at the expense of increase filling pressure (EDP).
Ventricular dilation
Tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What compensatory mechanisms of heart failure (Autonomic Nerves)

A

Autonomic Nerves:
Reduced BP initiates baroreceptor reflex - increases sympathetic adrenergic activity.
Reduced vagal activity to heart.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What compensatory mechanisms of heart failure (Hormones)

A

Hormones: Vasoconstriction of renal arteries increases hormone release.
Hormones Renin-angiotensin-aldosterone system
Vasopressin (antidiuretic hormone)
Circulating catecholamines
Natriuretic peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the cellular and molecular alterations in heart failure?

A

Changes occur in myocytes:

  1. alters contractile proteins
  2. alters calcium homeostasis
  3. alters signal transduction pathways (e.g. B adrenergic receptor signalling pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How are the contractile proteins altered in the failing heart?

A

Expression of myosin heavy chain isoforms are unchanged
ATPase activity are unchanged
Cross-bridge cycle rate is slower = causes a decrease in the maximal force developed
Phosphorylation state of troponin I is reduced due to decrease ac-cAMP-PKA pathway and affects the calcium sensitivity of the myofilament.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is calcium homeostasis altered in the failing heart?

A

Decline in intracellular calcium homeostasis.
Prolonged duration of action potential.
Systolic Ca2+ concentration (less clear whether it changes), increases threshold for Ca2+ release from SR, increases diastolic Ca2+ concentration. Decrease in Ca2+ reuptake of SR (due to dysfunction in the sarcoplasmic Calcium pump) and an increase in Na/Ca exchanger protein content.

17
Q

What happens to the signal transduction in the failing heart?

A

Decrease in B-adrenoreceptor number

Causing biochemical alteration in cAMP signalling pathway.

18
Q

E-C coupling can be impaired at several different sites during heart failure.

A

SR calcium stores are significantly reduced - depleted Ca2+ stores results in decreased contractile force.

Upregulation of Na/Ca exchanger- promotes removal of vital Ca2+ from the cell. Development of delayed depolarisation and triggers arrhythmias - impaction AP’s

Hyperphosphorylation of RyRs by adrenergic stimulation
Occurs as a compensatory mechanism to overcome this deficiency
PKA causes RyR malfunction and thus causing depletion of SR calcium and aberrant release of calcium during diastole (Calcium leak)

19
Q

What is the effect of Na+ causing intracellular Na and Ca overload?

A

Contractile dysfunction and arrhythmias

20
Q

Treating heart failure with ionotropic drugs

A

Ionotropic agents required to increase muscular contractile force.
Endogenous inotropic mechanisms include:
Contraction frequency dependent activation of contractile force.

21
Q

Drugs currently used to treat heart failure

A

Positive inotropic drugs:
Phosphodeisterase inhibitors
Catcholamine-mediated inotrophy

22
Q

How do inotropic agents regulate cardiac activity

A
  1. Increase force by the B-adrenoceptor-AC-cAMP system, PKA release phosphorylates L-type Ca channels, increase Ca influx and RyRs stimulation, increases SR calcium release thereby activation of cross bridges and contraction.
  2. Increase force by the B-adrenoceptor-AC-cAMP system, PKA release phosphorylates PLB, this accelerates SR accumulation of Ca2+ and relaxation.
23
Q

Catecholamine-mediates inotropy

A

Increase force by the B-adrenreceptor-AC system.

Stimulation of alpha-receptors.

24
Q

Nitric oxide causes

A

Defective NO release is one of the major factors involved in vasoconstriction in congestive heart failure.

25
Q

Phosphodiesterase 3 inhibitor example and effect

A

Milrinone (prevents conversion of cAMP to AMP therefore restores cAMP levels in cardiac myocytes and increases heart contractility)
Increases heart contractility
Vasodilators vessels
Helps to alleviate increased pressure (afterload) on the heart)

26
Q

B-adrenoreceptor stimulation drug treatment

A

dopamine, dobutamine

27
Q

Phosphodiesterase inhibition drug treatment

A

milrinone, enoximone

28
Q

Calcium sensitization drug treatment

A

Levosimendan

29
Q

Na-K ATPase inhibition plus SERCA activation drug treatment

A

Mercarbil

30
Q

SERCA activation plus vasodilation drug treatment

A

nitroxyl donor

31
Q

RyR stabilization drug treatment

A

Ryandodine receptor stabilizer S44121

32
Q

Energetic modulation drug treatment

A

Pyruvate